Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Hold at StockNews.com
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning. Several other equities research analysts also recently weighed in on IONS. William Blair reissued an outperform rating on shares of Ionis Pharmaceuticals in a report on Monday, November 13th. […]
More Stories
iShares ESG Advanced MSCI EAFE ETF (NASDAQ:DMXF) Short Interest Up 158.3% in January
iShares ESG Advanced MSCI EAFE ETF (NASDAQ:DMXF – Get Free Report) was the target of a significant increase in short...
WisdomTree Emerging Markets Quality Dividend Growth Fund (NASDAQ:DGRE) Short Interest Up 97.8% in January
WisdomTree Emerging Markets Quality Dividend Growth Fund (NASDAQ:DGRE – Get Free Report) saw a large increase in short interest in...
Calumet Specialty Products Partners (NASDAQ:CLMT) Stock Price Up 4.7% – Should You Buy?
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Free Report)’s stock price rose 4.7% during trading on Wednesday . The...
EnLink Midstream (NYSE:ENLC) Sees Unusually-High Trading Volume – Should You Buy?
EnLink Midstream, LLC (NYSE:ENLC – Get Free Report) shares saw an uptick in trading volume on Wednesday . 4,822,476 shares...
Brian Gleason Sells 3,135 Shares of Criteo S.A. (NASDAQ:CRTO) Stock
Criteo S.A. (NASDAQ:CRTO – Get Free Report) insider Brian Gleason sold 3,135 shares of Criteo stock in a transaction dated...
Next 15 Group (LON:NFG) Shares Down 10.6% – Should You Sell?
Shares of Next 15 Group plc (LON:NFG – Get Free Report) dropped 10.6% during trading on Wednesday . The company...